Tag: Keytruda

Moderna Stock Soars 50% After Melanoma Vaccine Succeeds in Phase 3 Trial

Moderna shares surged 50% after its cancer vaccine with Merck delayed melanoma recurrence in a late-stage trial, lifting the broader vaccine sector.

Merck Lifts Revenue Outlook on Strong Drug Sales but Trims Profit Forecast

Merck lifted its revenue outlook on strong new drug sales but trimmed its profit forecast to absorb charges tied to its Terns Pharmaceuticals acquisition.

- A word from our sponsors -

spot_img

Follow us

HomeTagsKeytruda